Cargando…

Identification of MCM4 as a Prognostic Marker of Hepatocellular Carcinoma

METHODS: MCM4 expression difference in HCC were analyzed from TCGA and GEO data and verified by real-time PCR and western blot. ROC curve was used to analyze the diagnostic value of MCM4 and AFP. Additionally, the relationship between MCM4 and stage or nodal metastasis status or grade or age in TCGA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Huandi, Jiang, Le, Wang, Guohui, Su, Linlin, Hou, Liubing, Xue, Xiaoying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710152/ https://www.ncbi.nlm.nih.gov/pubmed/34961841 http://dx.doi.org/10.1155/2021/7479326

Ejemplares similares

DNMT family induces down-regulation of NDRG1 via DNA methylation and clinicopathological significance in gastric cancer
por: Chang, Xiaojing, et al.
Publicado: (2021)

Upregulated Expression of Cancer-Derived Immunoglobulin G Is Associated With Progression in Glioma
por: Wang, Guohui, et al.
Publicado: (2021)

A Focal Adhesion-Related Gene Signature Predicts Prognosis in Glioma and Correlates With Radiation Response and Immune Microenvironment
por: Li, Haonan, et al.
Publicado: (2021)

SYST-23 CDK1 AS AN INDEPENDENT PROGNOSTIC INDICATOR AND POTENTIAL THERAPEUTIC TARGET IN GLIOMA
por: Wang, Yu, et al.
Publicado: (2023)

A Prognostic DNA Damage Repair Genes Signature and Its Impact on Immune Cell Infiltration in Glioma
por: Wang, Guohui, et al.
Publicado: (2021)

Identification of FABP7 as a Potential Biomarker for Predicting Prognosis and Antiangiogenic Drug Efficacy of Glioma
por: Hou, Liubing, et al.
Publicado: (2022)

The current management of alveolar soft part sarcomas
por: Chang, Xiaojing, et al.
Publicado: (2021)

Circular RNA: A novel type of biomarker for glioma
por: Sun, Wei, et al.
Publicado: (2021)

SDPS-17 COMPREHENSIVE ANALYSIS OF CELL DIVISION CYCLE ASSOCIATED GENE FAMILY EXPRESSION PATTERN AND PROGNOSIS VALUE REVEALS CDCA2 AS A NOVEL ONCOGENE FOR GLIOMA
por: Sun, Wei, et al.
Publicado: (2023)

NRAGE Confers Radiation Resistance in 2D and 3D Cell Culture and Poor Outcome in Patients With Esophageal Squamous Cell Carcinoma
por: Zhou, Huandi, et al.
Publicado: (2022)

IDH1(R132H) mutation increases radiotherapy efficacy and a 4-gene radiotherapy-related signature of WHO grade 4 gliomas
por: Han, Xuetao, et al.
Publicado: (2023)

Diagnostic and prognostic value of MCM3 and its interacting proteins in hepatocellular carcinoma
por: Li, Hong-Tao, et al.
Publicado: (2020)

Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5
por: Xu, Rongzhong, et al.
Publicado: (2021)

SDPS-28 THE STUDY OF AN ANOIKIS-RELATED SIGNATURE TO PREDICT GLIOMA PROGNOSIS AND IMMUNE INFILTRATION
por: Zhang, Dongdong, et al.
Publicado: (2023)

MELK is a prognostic biomarker and correlated with immune infiltration in glioma
por: Yang, Haiyan, et al.
Publicado: (2022)

MCM2 and TIP30 are prognostic markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of the gallbladder
por: Liu, Ziru, et al.
Publicado: (2016)

MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma
por: Qu, Kai, et al.
Publicado: (2017)

Correction to: MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma
por: Qu, Kai, et al.
Publicado: (2022)

ANXA1: An Important Independent Prognostic Factor and Molecular Target in Glioma
por: Zhang, Dongdong, et al.
Publicado: (2022)

Identification of the DNA Replication Regulator MCM Complex Expression and Prognostic Significance in Hepatic Carcinoma
por: Cao, Ting, et al.
Publicado: (2020)

SYST-16 ANXA5 PROMOTES GLIOMA PROGRESSION THROUGH THE FAK/PI3K/AKT PATHWAY
por: Zhang, Xinyuan, et al.
Publicado: (2023)

Identification of miRNAs as diagnostic and prognostic markers in hepatocellular carcinoma
por: Liang, Hao, et al.
Publicado: (2021)

Identification of KNOP1 as a prognostic marker in hepatocellular carcinoma
por: Zhang, Yaping, et al.
Publicado: (2023)

Bioinformatics Analysis Reveals MCM3 as an Important Prognostic Marker in Cervical Cancer
por: Ma, Hui, et al.
Publicado: (2021)

MCM2, MCM4, and MCM6 in Breast Cancer: Clinical Utility in Diagnosis and Prognosis()()
por: Issac, Marianne Samir Makboul, et al.
Publicado: (2019)

Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature
por: Zhao, Kaifei, et al.
Publicado: (2020)

RPNs Levels Are Prognostic and Diagnostic Markers for Hepatocellular Carcinoma
por: Zheng, Wangyang, et al.
Publicado: (2022)

Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma
por: Qiu, Jiliang, et al.
Publicado: (2011)

Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma
por: Yu, Zhenjun, et al.
Publicado: (2021)

Expression and Prognostic Value of MCM Family Genes in Osteosarcoma
por: Zhou, Jian, et al.
Publicado: (2021)

Minichromosome Maintenance (MCM) Family as potential diagnostic and prognostic tumor markers for human gliomas
por: Hua, Cong, et al.
Publicado: (2014)

MCM6 Promotes Hepatocellular Carcinoma Progression via the Notch Pathway: Clinical, Functional, and Genomic Insights
por: Hou, Liangjuan, et al.
Publicado: (2022)

MCM4 and MCM7, potential novel proliferation markers, significantly correlated with Ki-67, Bmi1, and cyclin E expression in esophageal adenocarcinoma, squamous cell carcinoma, and precancerous lesions(,)
por: Choy, Bonnie, et al.
Publicado: (2016)

High expression of carbonic anhydrase IX is significantly associated with glandular lesions in gastroesophageal junction and with tumorigenesis markers BMI1, MCM4 and MCM7
por: Huber, Aaron R., et al.
Publicado: (2015)

The relationship between PLOD1 expression level and glioma prognosis investigated using public databases
por: Tian, Lei, et al.
Publicado: (2021)

MCM2 promotes the stemness and sorafenib resistance of hepatocellular carcinoma cells via hippo signaling
por: Zhou, Xin, et al.
Publicado: (2022)

Juvenile Hormone-Receptor Complex Acts on Mcm4 and Mcm7 to Promote Polyploidy and Vitellogenesis in the Migratory Locust
por: Guo, Wei, et al.
Publicado: (2014)

Identification of prognostic immune cells and potential immune-related markers in hepatocellular carcinoma
por: Mai, Jialuo, et al.
Publicado: (2022)

MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma
por: Yang, Shu, et al.
Publicado: (2022)

Interactions of the Human MCM-BP Protein with MCM Complex Components and Dbf4
por: Nguyen, Tin, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_kni5upf8ced29eor7akhp3vi8q